Zhang Ling, Kanda Yoshiaki, Roberts Drucilla J, Ecker Jeffrey L, Losel Ralf, Wehling Martin, Peluso John J, Pru James K
Vincent Center for Reproductive Biology, Harvard Medical School, Boston, MA 02114, USA.
Mol Cell Endocrinol. 2008 Jun 11;287(1-2):81-9. doi: 10.1016/j.mce.2008.02.012. Epub 2008 Feb 29.
Although activation of the nuclear progesterone (P(4)) receptor (PGR) is required for uterine function, some of the actions of P(4) are mediated through a PGR-independent mechanism. The receptors that account for the PGR-independent actions have not been identified with certainty. The purpose of this study was to assess the expression, localization and hormonal regulation of two novel P(4) receptor candidates, P(4) receptor membrane component (PGRMC) 1 and PGRMC2, as well as the PGRMC1 partner Serpine 1 mRNA binding protein (SERBP1). Unlike Pgrmc1 and Serbp1, which remained unchanged throughout the estrous cycle, Pgrmc2 was highly up-regulated during proestrus and metestrus. Immunohistochemical analyses suggest that PGRMC1 and SERBP1 promote differentiation, since the expression of these proteins increased in endometrial cells undergoing steroid-depended terminal differentiation. Progesterone rather than estrogen appears to be primarily responsible for up-regulating the expression of PGRMCs. PGRMC1 and SERBP1 also showed overlapping patterns of expression in the human placenta and associated membranes with the most abundant expression in smooth muscle of the placental vasculature, villous capillaries and the syncytiotrophoblast. Based on these findings, it is proposed that PGRMC1:SERBP1 protein complex functions in events important to early pregnancy including cellular differentiation, modulation of apoptosis and steroidogenesis. These studies provide a platform from which to build a clearer understanding of P(4) actions in the female reproductive tract and placental tissues that are mediated by non-classical mechanisms.
虽然子宫功能需要核孕酮(P(4))受体(PGR)的激活,但P(4)的一些作用是通过不依赖PGR的机制介导的。尚未明确确定介导P(4)不依赖作用的受体。本研究的目的是评估两种新型P(4)受体候选物,即P(4)受体膜成分(PGRMC)1和PGRMC2,以及PGRMC1伴侣丝氨酸蛋白酶抑制剂1 mRNA结合蛋白(SERBP1)的表达、定位和激素调节。与在整个发情周期中保持不变的Pgrmc1和Serbp1不同,Pgrmc2在发情前期和发情后期高度上调。免疫组织化学分析表明,PGRMC1和SERBP1促进分化,因为这些蛋白质在经历类固醇依赖性终末分化的子宫内膜细胞中的表达增加。似乎主要是孕酮而非雌激素负责上调PGRMCs的表达。PGRMC1和SERBP1在人胎盘及相关膜中的表达模式也有重叠,在胎盘血管平滑肌、绒毛毛细血管和合体滋养层中表达最为丰富。基于这些发现,有人提出PGRMC1:SERBP1蛋白复合物在对早期妊娠重要的事件中发挥作用,包括细胞分化、细胞凋亡调节和类固醇生成。这些研究提供了一个平台,有助于更清楚地了解由非经典机制介导的P(4)在女性生殖道和胎盘组织中的作用。